Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|EPI-506||Ralaniten acetate||Hormone - Anti-androgens 38||EPI-506 (ralaniten acetate), the prodrug for EPI-002, is a small molecule that inhibits the N-terminal domain of the androgen receptor (AR), potentially resulting in decreased AR signaling, including in the context of mutant AR (PMID: 27628492, PMID: 27140928).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT02606123||Phase Ib/II||EPI-506||Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer||Terminated||USA | CAN||0|